1 / 42

Title Box

Title Box. Title Box. Title Box. Title Box. “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?.

onslow
Download Presentation

Title Box

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Title Box

  2. Title Box

  3. Title Box

  4. Title Box “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?

  5. “The journey of a thousand miles begins with one step” Lao Tzu

  6. Title Box “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?

  7. Title Box

  8. Title Box

  9. Title Box

  10. Title Box

  11. Title Box

  12. Title Box Chronic Immune Activation

  13. Title Box -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?

  14. Title Box ?

  15. Title Box A Roadmap to an HIV Cure

  16. Title Box

  17. What Have We Learned from Δ32/Δ32 stem cell transplantation? -HIV infection is critically dependent on CCR5 -HIV persistence is critically dependent on CCR5 -The role of tissues not derived from bone marrow in persistence and infection is in question But… n=1!

  18. What Have We Learned from the Elite Controllers? -Defined by the ability to spontaneously suppress plasma viremia -Occurs in less than 1% of HIV-infected individuals -Elevated CD4 cell counts, stable CD4 trajectories, and more favorable clinical outcomes -Overrepresentation of protective HLA alleles -Other mechanisms under active study -Immune Control of HIV infection is possible!

  19. Title Box -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?

  20. Title Box

  21. Title Box

  22. HIV Latency in CD4+ T cells - CD4+ T cell latency is established at the transcriptional level predominantly in central memory T cells -CD4+ T cell latency is rare (1/105-106 resting CD4 T cells) -Sequence of latent proviruses does not evolve, suggesting no or low ongoing viral replication. -Patients successfully treated with HAART for longer than 10 years exhibit no appreciable decrease in the size of the latent reservoir.

  23. Title Box ? ? ? ? Disulfiram

  24. Title Box

  25. HIV Latency at the Molecular Level

  26. HIV Latency at the Molecular Level

  27. Title Box

  28. HIV Latency at the Molecular Level

  29. HIV Latency at the Molecular Level

  30. HIV Latency at the Molecular Level

  31. HIV Latency at the Molecular Level

  32. Title Box

  33. Title Box

  34. Title Box -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART fail to cure and what are the mechanisms for HIV persistence during HAART? -How can we cure HIV?

  35. Title Box A Roadmap to an HIV Cure

  36. Title Box

  37. Title Box Jon Cohen, Science 2011;332:784

  38. IAS International Working Group

  39. Carine Van Lint Stephane Emiliiani Melanie Ott Albert Jordan Dwayne Bisgrove Tokameh Mahmoudi Maribel Parra Shweta Hakre Leonard Chavez Kotaro Shirakawa Vincenzo Calvanese Brigitte Autran Francoise Barre-Sinoussi Monsef Benkirane Nicolas Chomont Tae-Wook Chun Sharon Lewin Christine Rouzious Didier Trono

  40. Title Box Science 2010;329:174

  41. Title Box

More Related